2 Citations (Scopus)

Abstract

Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.

Original languageEnglish
Pages (from-to)414-417
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Volume5
Issue number2
Publication statusPublished - 06-05-2011

Fingerprint

Adrenergic beta-2 Receptor Agonists
Bronchoconstrictor Agents
Weighing
Meta-Analysis
Odds Ratio
Hypertension
Lung
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{537b18c839014be181d4c48a466ba2f6,
title = "β -blockers in reactive airway disease",
abstract = "Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.",
author = "Bharti Chogtu and Rahul Magazine and Bairy, {K. L.}",
year = "2011",
month = "5",
day = "6",
language = "English",
volume = "5",
pages = "414--417",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "2",

}

β -blockers in reactive airway disease. / Chogtu, Bharti; Magazine, Rahul; Bairy, K. L.

In: Journal of Clinical and Diagnostic Research, Vol. 5, No. 2, 06.05.2011, p. 414-417.

Research output: Contribution to journalReview article

TY - JOUR

T1 - β -blockers in reactive airway disease

AU - Chogtu, Bharti

AU - Magazine, Rahul

AU - Bairy, K. L.

PY - 2011/5/6

Y1 - 2011/5/6

N2 - Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.

AB - Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension, after weighing the risk: benefit ratio.

UR - http://www.scopus.com/inward/record.url?scp=79955570204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955570204&partnerID=8YFLogxK

M3 - Review article

VL - 5

SP - 414

EP - 417

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 2

ER -